Helix BioMedix, Inc. Reports Consecutive Record Revenue in the First Quarter 2011
BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the company’s first quarter ended March 31, 2011.